Adding vitamin D to medication reduces the likelihood of severe asthma attacks, according to research group the Cochrane Library.
The UK-based body – made up of a global network of researchers, professionals, patients, carers and more -, gathers and summarizes evidence from its contributors to help to make health decisions.
Its new review, titled Vitamin D for the management of asthma, noted that low blood levels of what is known as the ‘sunshine vitamin’ had been linked to increased attacks in children and adults with the condition.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze